StockData
BillionToOne, Inc. logo

BillionToOne, Inc. (BLLN) stock

BLLNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/30
$89.92−0.28 (-0.31%)

Close on Nov 20, 2026Market cap $4.24BP/E –Yield –

BillionToOne gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

BillionToOne's gross profit for the twelve months ending Sep 30, 2026 was $311.95M, up 88.4% year over year. For fiscal 2025 it was $208.46M, up 157.6% from the year before.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$208.46M+157.6%
FY2024Dec 31, 2024$80.92M+367.5%
FY2023Dec 31, 2023$17.31M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$87.15M+49.2%
Q2 FY2026Jun 30, 2026$77.11M+77.4%
Q1 FY2026Mar 31, 2026$79.10M+108.3%
Q4 FY2025Dec 31, 2025$68.60M+166.7%
Q3 FY2025Sep 30, 2025$58.42M+189.0%
Q2 FY2025Jun 30, 2025$43.47M–
Q1 FY2025Mar 31, 2025$37.97M–
Q4 FY2024Dec 31, 2024$25.72M–
Q3 FY2024Sep 30, 2024$20.22M–

More BillionToOne figures

See a number that looks wrong?